USPTO serial 79336665
ANIMAL FREE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 20, 2024
- Examiner
- CAYCEDO, CATHERINE ANN
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ANIMAL FREE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph T. Nabor
Joseph T. Nabor Fitch, Even, Tabin & Flannery, LLP120 S. LaSalle StreetSuite 2100Chicago, IL 60603Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; chemical preparations for use in photography; Chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial and synthetic resins; unprocessed plastics; compositions for fire extinguishing and prevention; tempering preparations; chemical preparations for soldering; chemical preparations for preserving foodstuffs; chemical products for tanning skins, namely, tanning agents for use in the manufacture of leather; chemical products for tanning hides, namely, tanning agents for use in the manufacture of leather; adhesives for use in industry; putties in the nature of oil cement putty and paste fillers for automobile body repair; compost, manures, fertilizers; biological preparations for use in industry and science; drug substances in the nature of active chemical ingredients for use in the manufacture of pharmaceuticals for treating cellulite, for anti-tumor therapies, for the treatment of cancer and for hormone replacement therapy | ACTIVE | — |
| 003 | Non-medicated cosmetics and toiletry preparations; non-medicated dentifrices; perfumery, essential oils; bleaching preparations for laundry use; laundry bleaching preparations; cleaning preparations; polishing preparations; scouring preparations; abrasive preparations | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of digestive disorders, for influencing blood clotting, for antiinflammatory therapies, for the treatment of immunological diseases, for wound cleaning and wound healing, for the treatment of connective tissue diseases, for the treatment of cellulite, for anti-tumor therapies, for the treatment of cancer and for hormone replacement therapy; sanitary preparations for medical use; veterinary preparations for mammals for the treatment of digestive disorders, for influencing blood clotting, for antiinflammatory therapies, for the treatment of immunological diseases, for wound cleaning and wound healing, for the treatment of connective tissue diseases, for the treatment of cellulite, for anti-tumor therapies, for the treatment of cancer and for hormone replacement therapy; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug substances in the nature of pharmaceutical preparations for the treatment of digestive disorders, for influencing blood clotting, for antiinflammatory therapies, for the treatment of immunological diseases, for wound cleaning and wound healing, for the treatment of connective tissue diseases, for the treatment of cellulite, for anti-tumor therapies, for the treatment of cancer and for hormone replacement therapy; medicine for the treatment of digestive disorders, for influencing blood clotting, for antiinflammatory therapies, for the treatment of immunological diseases, for wound cleaning and wound healing, for the treatment of connective tissue diseases, for the treatment of cellulite, for anti-tumor therapies, for the treatment of cancer and for hormone replacement therapy; enzymes for medical purposes; enzyme preparations for medical purposes; wound dressings, bandages for skin wounds and medical plasters impregnated with active ingredients; surgical implants comprising living tissue coated or filled with active ingredients; biological preparations for medical and veterinary purposes for the treatment of digestive disorders, for influencing blood clotting, for antiinflammatory therapies, for the treatment of immunological diseases, for wound cleaning and wound healing, for the treatment of connective tissue diseases, for the treatment of cellulite, for anti-tumor therapies, for the treatment of cancer and for hormone replacement therapy; sanitary preparations and articles in the nature of preparations for medical use; [ dietetic food adapted for medical use; ] dietetic food adapted for veterinary use; [ dietetic substances in the nature of preparations adapted for medical use; ] dietetic substances for veterinary use; food for babies; [ dietary supplements for humans; ] dietary supplements for animals; plasters for medical purposes, materials in the nature of surgical plasters for dressings; material for stopping teeth; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nordmark Pharma GmbH
- Other trademarks owned by Nordmark Pharma GmbH
- Other trademarks owned by Nordmark Pharma GmbH
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named ANIMAL FREE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 6, 2025 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| May 12, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 5, 2025 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 15, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Sep 16, 2024 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Sep 14, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Sep 11, 2024 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 11, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 27, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 7, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 6, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 22, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 21, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 21, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 20, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 20, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 14, 2024 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Oct 5, 2023 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Sep 16, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 5, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 5, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 30, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 30, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 16, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 16, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 16, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 29, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 25, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 24, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 24, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 11, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 11, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 11, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 10, 2023 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Apr 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 12, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 12, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 29, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 29, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 29, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 2, 2023 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Mar 2, 2023 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Feb 21, 2023 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Feb 10, 2023 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Feb 10, 2023 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Feb 10, 2023 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Dec 29, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 22, 2022 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Dec 6, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 6, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 23, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 22, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 25, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 24, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |